Alternatives to B Capital
The top Venture Capital companies similar to B Capital, ranked by relevance (named competitors first, then how closely their sectors overlap) and our 0-100 AI-readiness score. Each links to a full profile with funding and team.
- FOFounders Fund85Venture CapitalSan Francisco, USA$19.9B
General Catalyst50Venture CapitalCambridge, USA$63.0M
Index Ventures85Venture CapitalLondon, United Kingdom$9.1B- LALakestar70Venture CapitalBerlin, Germany$1.5B
- ICICONIQ Capital55Venture CapitalSan Francisco, United States$10.0B
MindWave Innovations51Biotechnology$100.0M- PHPhoenix Court50Venture CapitalLondon, United Kingdom$500.0M
- ANAntler50Venture CapitalSingapore, Singapore$63.0M
8VC29Venture CapitalAustin, United States$200.0M- LILightspeed Venture Partners26Venture CapitalMenlo Park, United States$52.5B
Owkin69Artificial IntelligenceNew York, USA$80.0M
Seedcamp66Venture CapitalLondon, United Kingdom$219.8M
Adocia62BiotechnologyLyon, France
Terremoto Biosciences62BiotechnologySouth San Francisco, USA$108.0M
Degron Therapeutics62BiotechnologySan Diego, USA$40.0M
Valar AI61Fintechתל אביב - יפו, Israel$2.4B- SUSupernus Pharmaceuticals60BiotechnologyRockville, United States$17.5M
CellCentric60BiotechnologyCambridge, United Kingdom$375.0M
Lazarus AI60Artificial IntelligenceNew York, USA$63.0M
Celerion59BiotechnologyLincoln, USA$45.0M
Rocket Pharmaceuticals58BiotechnologyCranbury, USA$382.9M- LŌLōkahi Therapeutics57BiotechnologyLa Jolla, USA$63.0M
Janux Therapeutics57BiotechnologySan Diego, USA$181.0M- BLBlackstone Life Sciences56Life SciencesNew York, USA$6.2B
ANATOMY55HealthcareNew York, United States$26.6M
Anagram Therapeutics55BiotechnologyNatick, USA$285.0M
Founders Factory55Venture CapitalLondon, United Kingdom$63.0M- ZEZero Gravity Capital55Venture CapitalBratislava, Slovakia$63.0M
Travere Therapeutics54BiotechnologySan Diego, USA$63.0M
Ray Therapeutics54BiotechnologyBerkeley, USA$243.0M- COCompass Pathways54BiotechnologyLondon, United Kingdom$294.0M
Tortugas Neuroscience53BiotechnologyFramingham, USA$164.0M- AMAmani Therapeutics53BiotechnologyNew York, USA$25.0M
Azurity Pharmaceuticals52PharmaceuticalsWoburn, United States$1.1B- GAGalderma Group52HealthcareZug, Switzerland$63.0M
- TRTreehub52Artificial IntelligenceLos Altos, USA$63.0M
- SPSpark Therapeutics52BiotechnologyPhiladelphia, United States$82.8M
Renaissance Philanthropy52PhilanthropyNew York, United States$214.0M
ONCOMATRYX51BiotechnologyDerio, Spain$106.8M- PRPresto Ventures II51Venture CapitalBratislava, Slovakia$225.0M
PSV Tech50Venture CapitalNew York, United States- SASatori Investment Partners50Venture CapitalSan Francisco, United States$100.0M
Northzone50Venture CapitalStockholm, Sweden$630.0M
EnteroBiotix50BiotechnologyGlasgow, United Kingdom$40.5M
ImmunityBio50BiotechnologyCulver City, USA$75.0M
RockawayX50Venture CapitalTel Aviv, Israel$200.0M
TIXiMED49BiotechnologyBirmingham, United States$4.8M
Orthogon Therapeutics49BiotechnologyCanton, USA$34.6M- TGTG Therapeutics49BiotechnologyNew York, USA$360.0M
Homebrew49Venture CapitalBurlingame, United States$400.0M
Project A Ventures48Venture CapitalBerlin, Germany$63.0M
Deep Science Ventures47BiotechnologyLondon, United Kingdom$63.0M
Quince Therapeutics46BiotechnologySouth San Francisco, USA$63.0M- ANAN2 Therapeutics46BiotechnologyMenlo Park, United States$132.0M
Alomana45Artificial IntelligenceMilan, Italy$4.4M
Cleo Capital44Venture CapitalParis, France$3.8M
Adaptimmune Therapeutics44BiotechnologyAbingdon, United Kingdom$107.5M- DIDiaMedica Therapeutics43BiotechnologyMinneapolis, United States$30.1M
Hoxton Ventures43Venture CapitalLondon, United Kingdom$63.0M- SASamaipata43Venture CapitalMadrid, Spain$110.0M
| Company | Sector | HQ | Funding | Score |
|---|---|---|---|---|
| FOFounders Fund | Venture Capital | San Francisco, USA | $19.9B | 85 |
| Venture Capital | Cambridge, USA | $63.0M | 50 | |
| Venture Capital | London, United Kingdom | $9.1B | 85 | |
| LALakestar | Venture Capital | Berlin, Germany | $1.5B | 70 |
| ICICONIQ Capital | Venture Capital | San Francisco, United States | $10.0B | 55 |
| Biotechnology | — | $100.0M | 51 | |
| PHPhoenix Court | Venture Capital | London, United Kingdom | $500.0M | 50 |
| ANAntler | Venture Capital | Singapore, Singapore | $63.0M | 50 |
| Venture Capital | Austin, United States | $200.0M | 29 | |
| LILightspeed Venture Partners | Venture Capital | Menlo Park, United States | $52.5B | 26 |
| Artificial Intelligence | New York, USA | $80.0M | 69 | |
| Venture Capital | London, United Kingdom | $219.8M | 66 | |
| Biotechnology | Lyon, France | — | 62 | |
| Biotechnology | South San Francisco, USA | $108.0M | 62 | |
| Biotechnology | San Diego, USA | $40.0M | 62 | |
| Fintech | תל אביב - יפו, Israel | $2.4B | 61 | |
| SUSupernus Pharmaceuticals | Biotechnology | Rockville, United States | $17.5M | 60 |
| Biotechnology | Cambridge, United Kingdom | $375.0M | 60 | |
| Artificial Intelligence | New York, USA | $63.0M | 60 | |
| Biotechnology | Lincoln, USA | $45.0M | 59 | |
| Biotechnology | Cranbury, USA | $382.9M | 58 | |
| LŌLōkahi Therapeutics | Biotechnology | La Jolla, USA | $63.0M | 57 |
| Biotechnology | San Diego, USA | $181.0M | 57 | |
| BLBlackstone Life Sciences | Life Sciences | New York, USA | $6.2B | 56 |
| Healthcare | New York, United States | $26.6M | 55 | |
| Biotechnology | Natick, USA | $285.0M | 55 | |
| Venture Capital | London, United Kingdom | $63.0M | 55 | |
| ZEZero Gravity Capital | Venture Capital | Bratislava, Slovakia | $63.0M | 55 |
| Biotechnology | San Diego, USA | $63.0M | 54 | |
| Biotechnology | Berkeley, USA | $243.0M | 54 | |
| COCompass Pathways | Biotechnology | London, United Kingdom | $294.0M | 54 |
| Biotechnology | Framingham, USA | $164.0M | 53 | |
| AMAmani Therapeutics | Biotechnology | New York, USA | $25.0M | 53 |
| Pharmaceuticals | Woburn, United States | $1.1B | 52 | |
| GAGalderma Group | Healthcare | Zug, Switzerland | $63.0M | 52 |
| TRTreehub | Artificial Intelligence | Los Altos, USA | $63.0M | 52 |
| SPSpark Therapeutics | Biotechnology | Philadelphia, United States | $82.8M | 52 |
| Philanthropy | New York, United States | $214.0M | 52 | |
| Biotechnology | Derio, Spain | $106.8M | 51 | |
| PRPresto Ventures II | Venture Capital | Bratislava, Slovakia | $225.0M | 51 |
| Venture Capital | New York, United States | — | 50 | |
| SASatori Investment Partners | Venture Capital | San Francisco, United States | $100.0M | 50 |
| Venture Capital | Stockholm, Sweden | $630.0M | 50 | |
| Biotechnology | Glasgow, United Kingdom | $40.5M | 50 | |
| Biotechnology | Culver City, USA | $75.0M | 50 | |
| Venture Capital | Tel Aviv, Israel | $200.0M | 50 | |
| Biotechnology | Birmingham, United States | $4.8M | 49 | |
| Biotechnology | Canton, USA | $34.6M | 49 | |
| TGTG Therapeutics | Biotechnology | New York, USA | $360.0M | 49 |
| Venture Capital | Burlingame, United States | $400.0M | 49 | |
| Venture Capital | Berlin, Germany | $63.0M | 48 | |
| Biotechnology | London, United Kingdom | $63.0M | 47 | |
| Biotechnology | South San Francisco, USA | $63.0M | 46 | |
| ANAN2 Therapeutics | Biotechnology | Menlo Park, United States | $132.0M | 46 |
| Artificial Intelligence | Milan, Italy | $4.4M | 45 | |
| Venture Capital | Paris, France | $3.8M | 44 | |
| Biotechnology | Abingdon, United Kingdom | $107.5M | 44 | |
| DIDiaMedica Therapeutics | Biotechnology | Minneapolis, United States | $30.1M | 43 |
| Venture Capital | London, United Kingdom | $63.0M | 43 | |
| SASamaipata | Venture Capital | Madrid, Spain | $110.0M | 43 |